Primary lateral sclerosis (PLS) functional rating scale: PLS‐specific clinimetric scale

• Published in: Muscle & nerve Vol. 61; no. 2; pp. 163 - 172
• Main Authors: Mitsumoto, Hiroshi, Chiuzan, Codruta, Gilmore, Madison, Zhang, Yuan, Simmons, Zachary, Paganoni, Sabrina, Kisanuki, Yasushi Y., Zinman, Lorne, Jawdat, Omar, Sorenson, Eric, Floeter, Mary Kay, Pioro, Erik P., Fernandes Filho, J. Americo M., Heitzman, Daragh, Fournier, Christina Nicole, Oskarsson, Bjorn, Heiman‐Patterson, Terry, Maragakis, Nicholas, Joyce, Nanette, Hayat, Ghazala, Nations, Sharon, Scelsa, Stephen, Walk, David, Elman, Lauren, Hupf, Jonathan, McHale, Brittany
• Format: Journal Article
• Language: English
• Published: Hoboken, USA John Wiley & Sons, Inc 01.02.2020; Wiley Subscription Services, Inc
• Subjects: Activities of Daily Living; Adult; Aged; Caregivers; Certification; clinical trials; clinimetric scale; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; MND; Motor Neuron Disease - diagnosis; Motor Neuron Disease - physiopathology; Motor Neuron Disease - psychology; Motor neuron diseases; Observer Variation; PLS; PLSFRS; PUMND; Quality of Life; Reproducibility of Results; Telephone; PUMND; clinimetric scale; PLSFRS; MND; clinical trials; PLS
• ISSN: 0148-639X; 1097-4598
• DOI: 10.1002/mus.26765

Introduction Our research aim was to develop a novel clinimetric scale sensitive enough to detect disease progression in primary lateral sclerosis (PLS). Methods A prototype of the PLS Functional Rating Scale (PLSFRS) was generated. Seventy‐seven participants with PLS were enrolled and evaluated at 21 sites that comprised the PLSFRS study group. Participants were assessed using the PLSFRS, Neuro‐Quality of Life (QoL), Schwab‐England Activities of Daily Living (ADL), and the Clinical Global Impression of Change scales. Participants completed telephone assessments at 12, 24, and 48 weeks after enrollment. Results The PLSFRS demonstrated internal consistency as well as intrarater, interrater, telephone test‐retest reliability, and construct validity. Significant changes in disease progression were detected at 6 and 12 months; changes measured by the PLSFRS vs the ALSFRS‐R were significantly higher. Discussion The PLSFRS is a valid tool to assess the natural history of PLS in a shorter study period.